BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Stojsavljević S, Gomerčić Palčić M, Virović Jukić L, Smirčić Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(48): 18070-18091 [PMID: 25561778 DOI: 10.3748/wjg.v20.i48.18070]
URL: https://www.wjgnet.com/1948-5182/full/v20/i48/18070.htm
Number Citing Articles
1
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng. Association of metabolic dysfunction-associated fatty liver disease with kidney diseaseNature Reviews Nephrology 2022; 18(4): 259 doi: 10.1038/s41581-021-00519-y
2
Sandra Andreotti, Ayumi Cristina Medeiros Komino, Flaviane de Fatima Silva, Ana Paula Almeida Ramos, Noemi Lourenço Gil, Gabriela Araujo Azevedo, Rogerio Antonio Laurato Sertié, Fabio Bessa Lima, Richardt Gama Landgraf, Maristella Almeida Landgraf. Intrauterine food restriction impairs the lipogenesis process in the mesenteric adipocytes from low-birth-weight rats into adulthoodFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1259854
3
Shui-Xian Du, Lin-Lin Lu, Yang Liu, Quan-Jiang Dong, Shi-Ying Xuan, Yong-Ning Xin. Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.37388
4
Huashan Li, Jianying Sheng, Jing Wang, Haiting Gao, Jing Yu, Guoxian Ding, Ning Ding, Weiqi He, Juanmin Zha. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in MiceDrug Design, Development and Therapy 2021; : 2309 doi: 10.2147/DDDT.S285828
5
Lorena Bavia, Bruno Cogliati, Juliano Bertollo Dettoni, Venancio Avancini Ferreira Alves, Lourdes Isaac. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease modelImmunology Letters 2016; 177: 53 doi: 10.1016/j.imlet.2016.07.014
6
Cemal Nuri Ercin, Teoman Dogru, Halil Genc, Gurkan Celebi, Fatih Aslan, Hasan Gurel, Muammer Kara, Erdim Sertoglu, Serkan Tapan, Sait Bagci, Manfredi Rizzo, Alper Sonmez. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver DiseaseMetabolic Syndrome and Related Disorders 2015; 13(7): 319 doi: 10.1089/met.2015.0018
7
Shigeru Murakami, Ayuko Ono, Azusa Kawasaki, Takaaki Takenaga, Takashi Ito. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitroAmino Acids 2018; 50(9): 1279 doi: 10.1007/s00726-018-2605-8
8
Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver diseaseInflammation Research 2020; 69(9): 851 doi: 10.1007/s00011-020-01373-7
9
Touraj Mahmoudi, Donya Ghorbani, Gholamreza Rezamand, Niloufar Dehestan, Golnaz Jeddi, Asadollah Asadi, Hossein Nobakht, Reza Dabiri, Hamid Farahani, Seidamir Pasha Tabaeian, Mohammad Reza Zali. A visfatin gene promoter polymorphism (rs1319501) is associated with susceptibility to nonalcoholic fatty liver diseasePersonalized Medicine 2023; 20(2): 157 doi: 10.2217/pme-2022-0100
10
Karen R. Jonscher, Robert B. Rucker. Dietary Interventions in Liver Disease2019; : 157 doi: 10.1016/B978-0-12-814466-4.00013-6
11
Silvano Junior Santini, Cristiana Porcu, Giovanni Tarantino, Fernanda Amicarelli, Clara Balsano. Oleuropein overrides liver damage in steatotic miceJournal of Functional Foods 2020; 65: 103756 doi: 10.1016/j.jff.2019.103756
12
Asad Mirzaei, Asma Asal, Ali Seidkhani-Nahal, Ali Noori-Zadeh. A systematic review and meta-analysis of serum resistin level and its relation to HOMA-IR score using meta-regression in nonalcoholic fatty liver disease patientsMediterranean Journal of Nutrition and Metabolism 2021; 14(3): 219 doi: 10.3233/MNM-210538
13
Obesity and Breast Cancer: Molecular and Epidemiological EvidenceJournal of Cancer Research Updates 2015; 4(1) doi: 10.6000/1929-2279.2015.04.01.3
14
Noha El Nakeeb, Shereen A Saleh, Yasmine M Massoud, Ahmed Hussein, Rana Hamed. Serum ferritin as a non‐invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non‐alcoholic fatty liver diseaseJGH Open 2017; 1(3): 112 doi: 10.1002/jgh3.12019
15
Antonio Olveira, Pedro Herranz, María Luisa Montes. Psoriasis and fatty liver: a harmful synergyRevista Española de Enfermedades Digestivas 2019; 111: 314 doi: 10.17235/reed.2019.6263/2019
16
Ai‐rong Zhang, Jing Sun, Yuan He, Ning Wang, Li Tian. Attenuation of lipid accumulation in Bel‐7402 cells through ADPN/AMPKα signaling stimulated by Fructus rosae laxae extractJournal of Food Biochemistry 2020; 44(12) doi: 10.1111/jfbc.13497
17
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in MiceHepatology 2018; 68(5): 1769 doi: 10.1002/hep.30066
18
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver DiseaseChinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
19
Abdelghany Hassan Abdelghany, Mohammad A. BaSalamah, Shakir Idris, Jawwad Ahmad, Bassem Refaat. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in ratsJournal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1040-4
20
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and PathophysiologyMiddle East Journal of Digestive Diseases 2022; 14(2): 167 doi: 10.34172/mejdd.2022.270
21
Ji Eun Heo, Dong Gyun Kim, Jeong Woo Yoo, Kwang Suk Lee. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean malesThe Aging Male 2023; 26(1) doi: 10.1080/13685538.2023.2166920
22
Darmadi Darmadi, Riska Habriel Ruslie. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD)Romanian Journal of Internal Medicine 2021; 59(1): 66 doi: 10.2478/rjim-2020-0029
23
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
24
Sara Raia, Antonio Conti, Alan Zanardi, Barbara Ferrini, Giulia Maria Scotti, Enrica Gilberti, Giuseppe De Palma, Samuel David, Massimo Alessio. Ceruloplasmin-Deficient Mice Show Dysregulation of Lipid Metabolism in Liver and Adipose Tissue Reduced by a Protein ReplacementInternational Journal of Molecular Sciences 2023; 24(2): 1150 doi: 10.3390/ijms24021150
25
Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose dietScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
26
Smitha Krishnan, Yufang Ding, Nima Saedi, Maria Choi, Gautham V. Sridharan, David H. Sherr, Martin L. Yarmush, Robert C. Alaniz, Arul Jayaraman, Kyongbum Lee. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and MacrophagesCell Reports 2018; 23(4): 1099 doi: 10.1016/j.celrep.2018.03.109
27
Jun-Qi Shi, Wen-Xia Shen, Xiang-Zhi Wang, Ke Huang, Chao-Chun Zou. Relationship between immune parameters and non-alcoholic fatty liver disease in obese childrenIndian Pediatrics 2017; 54(10): 825 doi: 10.1007/s13312-017-1143-x
28
Aoife N. O’Donovan, Florence M. Herisson, Fiona Fouhy, Paul M. Ryan, Derek Whelan, Crystal N. Johnson, Gaston Cluzel, R. Paul Ross, Catherine Stanton, Noel M. Caplice. Gut microbiome of a porcine model of metabolic syndrome and HF-pEFAmerican Journal of Physiology-Heart and Circulatory Physiology 2020; 318(3): H590 doi: 10.1152/ajpheart.00512.2019
29
Ayokanmi Ore, Oluseyi Adeboye Akinloye. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental InterventionsMedicina 2021; 57(8): 822 doi: 10.3390/medicina57080822
30
Adriano Lama, Claudio Pirozzi, Maria Pia Mollica, Giovanna Trinchese, Francesca Di Guida, Gina Cavaliere, Antonio Calignano, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed ratsMolecular Nutrition & Food Research 2017; 61(3) doi: 10.1002/mnfr.201600418
31
Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao. Hepatic Macrophage as a Key Player in Fatty Liver DiseaseFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708978
32
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse ModelPLOS ONE 2016; 11(5): e0154676 doi: 10.1371/journal.pone.0154676
33
Lingling Ding, Toon. J. I. De Munck, Yvonne Oligschlaeger, Inês Magro dos Reis, Jef Verbeek, Ger. H. Koek, Tom Houben, Ronit Shiri-Sverdlov. Myosteatosis in NAFLD patients correlates with plasma Cathepsin DBiomolecular Concepts 2021; 12(1): 27 doi: 10.1515/bmc-2021-0004
34
Ying-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wang. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling PathwayFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.605064
35
Xiaojing Wang, Lan Li, Hongwu Wang, Fang Xiao, Qin Ning. Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in miceScandinavian Journal of Immunology 2019; 90(3) doi: 10.1111/sji.12791
36
Jingyi Guo, Shangyi Huang, Qincheng Yi, Naihua Liu, Tianqi Cui, Siwei Duan, Jiabing Chen, Jiayu Li, Jun Li, Lei Wang, Yong Gao, Guangning Nie. Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXRACS Omega 2023; 8(29): 26158 doi: 10.1021/acsomega.3c02347
37
Daqing Zhang, Zhen Mi, Jiya Peng, Tiangui Yang, Yuze Han, Yujia Zhai, Chenliang Song, Xianzhuo Teng, Wei Sun, Jing Guo, Kabeya Paulin Bilonda. Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular DiseasesJournal of Cardiovascular Pharmacology 2023; 81(5): 327 doi: 10.1097/FJC.0000000000001418
38
Ji-Young Cha, Da-Hyun Kim, Kyung-Hee Chun. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisLaboratory Animal Research 2018; 34(4): 133 doi: 10.5625/lar.2018.34.4.133
39
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?Current HIV/AIDS Reports 2018; 15(3): 212 doi: 10.1007/s11904-018-0392-1
40
Daniel Costache, Horia Blejan, Damian Cojocaru, Georgiana Ioniță, Marcela Poenaru, Maria Constantin, Andrei Costache, Constantin Căruntu, Daniel Balaban, Raluca Costache. Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet—A Comprehensive ReviewInternational Journal of Molecular Sciences 2024; 25(5): 2660 doi: 10.3390/ijms25052660
41
Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseHepatology Communications 2018; 2(11): 1344 doi: 10.1002/hep4.1237
42
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
43
Cheng‐Chung Li, Chun Liu, Maobin Fu, Kang‐Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang‐Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in MiceMolecular Nutrition & Food Research 2018; 62(8) doi: 10.1002/mnfr.201700738
44
Silvia M. Ferolla. Obesity2016; : 159 doi: 10.1007/978-3-319-19821-7_13
45
Minghui Zheng, Jing Li, Weizhen Fang, Ling Luo, Rui Ding, Hua Zeng, Hong Luo, Xianghua Lin, Chaohui Duan. The TNF-α rs361525 and IFN-γ rs2430561 polymorphisms are associated with liver cirrhosis risk: a comprehensive meta-analysisFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1129767
46
Hee Jae Lee, Yunsook Lim, Soo Jin Yang. Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitroThe Journal of Nutritional Biochemistry 2015; 26(11): 1254 doi: 10.1016/j.jnutbio.2015.06.001
47
M. A. Livzan, T. S. Krolevets, S. I. Mozgovoy, N. A. Nikolaev, A. V. Nelidova. Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver diseaseTerapevticheskii arkhiv 2021; 93(2): 222 doi: 10.26442/00403660.2021.02.200614
48
Gamal A. Salem, Amany Abdel-Rahman Mohamed, Safaa I. Khater, Ahmed E. Noreldin, Manal Alosaimi, Wafa S. Alansari, Ghalia Shamlan, Areej A. Eskandrani, Marwa Mahmoud Awad, Rehab Ahmed Ahmed El-Shaer, Mohamed A. Nassan, Mahmoud Mostafa, Tarek Khamis. Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genesGene 2023; 883: 147670 doi: 10.1016/j.gene.2023.147670
49
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic ImplicationsJournal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
50
Magdalena Losko, Jerzy Kotlinowski, Jolanta Jura. Long Noncoding RNAs in Metabolic Syndrome Related DisordersMediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/5365209
51
Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang. A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective studyExperimental and Therapeutic Medicine 2022; 24(3) doi: 10.3892/etm.2022.11536
52
Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga. Investigating fibrosis and inflammation in an ex vivo NASH murine modelAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(2): G336 doi: 10.1152/ajpgi.00209.2019
53
Huicun Zhang, Xiang Gao, Pengmin Chen, Hongbing Wang. Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 InflammasomeFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.851267
54
Ye Rim Nam, Sae Bom Won, Young-Shin Chung, Chung Shil Kwak, Young Hye Kwon. Inhibitory effects ofDoenjang, Korean traditional fermented soybean paste, on oxidative stress and inflammation in adipose tissue of mice fed a high-fat dietNutrition Research and Practice 2015; 9(3): 235 doi: 10.4162/nrp.2015.9.3.235
55
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
56
Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model ratsJournal of Pharmacy and Pharmacology 2018; 70(3): 383 doi: 10.1111/jphp.12870
57
Chifa Ma, Yiwen Liu, Shuli He, Jingbo Zeng, Pingping Li, Chunxiao Ma, Fan Ping, Huabing Zhang, Lingling Xu, Wei Li, Yuxiu Li. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid LevelsFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.600472
58
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate HyperplasiaJournal of Korean Medical Science 2020; 35(22) doi: 10.3346/jkms.2020.35.e164
59
P. Shabani, S. Emamgholipour, M. Doosti. Advances in Clinical Chemistry 2017; 79: 1 doi: 10.1016/bs.acc.2016.10.002
60
Chan Yoon Park, Tae Yeon Kim, Ji Su Yoo, Yeonkyung Seo, Munkyong Pae, Sung Nim Han. Effects of 1,25-Dihydroxyvitamin D3 on the Inflammatory Responses of Stromal Vascular Cells and Adipocytes from Lean and Obese MiceNutrients 2020; 12(2): 364 doi: 10.3390/nu12020364
61
Eunhui Seo, Yoon Sin Oh, Hee-Sook Jun. Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese MiceNutrients 2016; 8(2): 83 doi: 10.3390/nu8020083
62
Viviana Casagrande, Alessandro Mauriello, Simone Bischetti, Maria Mavilio, Massimo Federici, Rossella Menghini. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06439-x
63
Ioana Corina Bocsan, Mircea Vasile Milaciu, Raluca Maria Pop, Stefan Cristian Vesa, Lorena Ciumarnean, Daniela Maria Matei, Anca Dana Buzoianu. Cytokines Genotype-Phenotype Correlation in Nonalcoholic SteatohepatitisOxidative Medicine and Cellular Longevity 2017; 2017: 1 doi: 10.1155/2017/4297206
64
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-based novel biomarkers for nonalcoholic steatohepatitisBiomarkers in Medicine 2018; 12(5): 501 doi: 10.2217/bmm-2017-0361
65
Mirella Pastore, Alessandra Gentilini, Fabio Marra. Non-Alcoholic Fatty Liver Disease2020; : 97 doi: 10.1007/978-3-319-95828-6_6
66
Chieh Chen. The role of adipokines in the disease of metabolic-associated fatty liver diseaseTungs' Medical Journal 2023; 17(2): 49 doi: 10.4103/ETMJ.ETMJ-D-23-00015
67
Young Hwan Jang, Dong Hyun In, Jae Kook Yang, Hyuk Jin Moon, Gyu Tae Yoon, Ah Jeong Ryu, Yeo Joo Kim, Eun Young Lee, Hyun Jin Kim, Bon Jeong Ku, Jae Min Lee, Kang Seo Park, In Suk Lee, Jong Min Lee, Dong Mee Lim, Keun Yong Park, Sang Jin Kim. The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective StudyThe Journal of Korean Diabetes 2015; 16(4): 303 doi: 10.4093/jkd.2015.16.4.303
68
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
69
Yu-Lin Chao, Pei-Yu Wu, Jiun-Chi Huang, Yi-Wen Chiu, Jia-Jung Lee, Szu-Chia Chen, Jer-Ming Chang, Shang-Jyh Hwang, Hung-Chun Chen. Hepatic Steatosis Is Associated with High White Blood Cell and Platelet CountsBiomedicines 2022; 10(4): 892 doi: 10.3390/biomedicines10040892
70
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
71
Carmelo Luci, Elodie Vieira, Thibaut Perchet, Philippe Gual, Rachel Golub. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver DiseaseFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01192
72
Wen Liu, Fuxiang Bai, Hongxing Wang, Yan Liang, Xianhong Du, Cui Liu, Dejian Cai, Jiali Peng, Guangming Zhong, Xiaohong Liang, Chunhong Ma, Lifen Gao. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in MacrophagesThe Journal of Immunology 2019; 203(4): 990 doi: 10.4049/jimmunol.1900117
73
Monica Dinu, Anne Whittaker, Giuditta Pagliai, Ilaria Giangrandi, Barbara Colombini, Anna Maria Gori, Claudia Fiorillo, Matteo Becatti, Alessandro Casini, Stefano Benedettelli, Francesco Sofi. A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical TrialJournal of the American College of Nutrition 2018; 37(6): 508 doi: 10.1080/07315724.2018.1445047
74
Shunqin Wang, Jingsong Liu, Junfeng Zhang, Jiancheng Lin, Shuyu Yang, Jiangwu Yao, Minquan Du. Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitisBrazilian Oral Research 2017; 31(0) doi: 10.1590/1807-3107bor-2017.vol31.0090
75
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
76
Emilio Molina‐Molina, Guilherme Eustaquio. Furtado, John G. Jones, Piero Portincasa, Ana Vieira‐Pedrosa, Ana Maria Teixeira, Marcelo Paes Barros, André Luís Lacerda Bachi, Vilma A. Sardão. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal womenEuropean Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13731
77
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
78
Jari E. Kaikkonen, Petri Kresanov, Markku Ahotupa, Antti Jula, Vera Mikkilä, Jorma S. A. Viikari, Markus Juonala, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Antti J. Kangas, Pasi Soininen, Mika Ala-Korpela, Olli T. Raitakari. Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns StudyFree Radical Research 2016; 50(4): 396 doi: 10.3109/10715762.2015.1133906
79
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver DiseasesJournal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
80
Johannes Sollner. Vaccine DesignMethods in Molecular Biology 2016; 1403: 107 doi: 10.1007/978-1-4939-3387-7_5
81
The effect of complex treatment of patients with non-alcoholic steatohepatitis in combination with type 2 diabetes on the course of the inflammatory process: adiponectin and proinflammatory cytokinesFamily medicine 2018; (3): 53 doi: 10.30841/2307-5112.3.2018.146359
82
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic SteatohepatitisInflammation 2019; 42(3): 1056 doi: 10.1007/s10753-019-00967-6
83
Sara Parrettini, Massimiliano Cavallo, Francesco Gaggia, Riccardo Calafiore, Giovanni Luca. Adipokines: A Rainbow of Proteins with Metabolic and Endocrine FunctionsProtein & Peptide Letters 2020; 27(12): 1204 doi: 10.2174/0929866527666200505214555
84
Yuling Xing, Jinhu Chen, Jing Liu, Guangyao Song, Huijuan Ma. Relationship Between Serum Uric Acid-to-Creatinine Ratio and the Risk of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes MellitusDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 257 doi: 10.2147/DMSO.S350468
85
Qian Wang, Dehai Li, Jing Zhu, Mingyue Zhang, Hua Zhang, Guangchao Cao, Leqing Zhu, Qiping Shi, Jianlei Hao, Qiong Wen, Zonghua Liu, Hengwen Yang, Zhinan Yin. Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLDFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00846
86
Kun Tang, Fei Wang, Yi Zeng, XueMeng Chen, XiaoLe Xu. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient miceEuropean Journal of Pharmacology 2018; 830: 76 doi: 10.1016/j.ejphar.2018.04.026
87
Petra Surlin, Andreea Cristiana Didilescu, Luminita Lazar, Cristian Cosmin Arsenie, Adrian Camen, Dora Maria Popescu, Dorin Nicolae Gheorghe, Eugen Osiac, Ion Rogoveanu. Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal PatientsDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 2935 doi: 10.2147/DMSO.S310314
88
Md Monirujjaman, Oliver F. Bathe, Vera C. Mazurak. Dietary EPA+DHA Mitigate Hepatic Toxicity and Modify the Oxylipin Profile in an Animal Model of Colorectal Cancer Treated with ChemotherapyCancers 2022; 14(22): 5703 doi: 10.3390/cancers14225703
89
Wen-Chung Huang, Po-Chen Liao, Chun-Hsun Huang, Sindy Hu, Shih-Chun Huang, Shu-Ju Wu. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cellsBiomedicine & Pharmacotherapy 2017; 91: 78 doi: 10.1016/j.biopha.2017.04.051
90
Lauren Barron, Cathleen Courtney, James Bao, Emily Onufer, Roheena Z. Panni, Bola Aladegbami, Brad W. Warner. Intestinal resection-associated metabolic syndromeJournal of Pediatric Surgery 2018; 53(6): 1142 doi: 10.1016/j.jpedsurg.2018.02.077
91
Panagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis. Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerationsWorld Journal of Gastroenterology 2022; 28(39): 5691-5706 doi: 10.3748/wjg.v28.i39.5691
92
Evelyn Nunes Goulart da Silva Pereira, Beatriz Peres de Araujo, Karine Lino Rodrigues, Raquel Rangel Silvares, Carolina Souza Machado Martins, Edgar Eduardo Ilaquita Flores, Caroline Fernandes-Santos, Anissa Daliry. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE StressNutrients 2022; 14(3): 716 doi: 10.3390/nu14030716
93
Hon-Jhe Chen, Hao-Yu Yang, Kuang-Chieh Hsueh, Cheng-Che Shen, Ru-Yi Chen, Hsien-Chung Yu, Tzu-Lin Wang. Increased risk of osteoporosis in patients with nonalcoholic fatty liver diseaseMedicine 2018; 97(42): e12835 doi: 10.1097/MD.0000000000012835
94
Lili Chen, Xiaolong Zhao, Guangjun Liang, Jiuru Sun, Zhifeng Lin, Renming Hu, Peili Chen, Zhaoyun Zhang, Linuo Zhou, Yiming Li. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitisNutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0208-0
95
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Seyed Ali Malek-Hosseini. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitisUnited European Gastroenterology Journal 2018; 6(1): 97 doi: 10.1177/2050640617707863
96
Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver DiseaseGenes 2019; 10(12): 966 doi: 10.3390/genes10120966
97
Alice Yuxin Wang, Jasbir Dhaliwal, Marialena Mouzaki. Lean non-alcoholic fatty liver diseaseClinical Nutrition 2019; 38(3): 975 doi: 10.1016/j.clnu.2018.08.008
98
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Adipokines in nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1062 doi: 10.1016/j.metabol.2015.11.006
99
Sangam Rajak. Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4): 167102 doi: 10.1016/j.bbadis.2024.167102
100
Maja Cigrovski Berkovic, Lucija Virovic-Jukic, Ines Bilic-Curcic, Anna Mrzljak. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and managementWorld Journal of Gastroenterology 2020; 26(21): 2740-2757 doi: 10.3748/wjg.v26.i21.2740
101
Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De-Xing Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat DietMolecules 2018; 23(12): 3213 doi: 10.3390/molecules23123213
102
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2020; 21(11): 4189 doi: 10.3390/ijms21114189
103
Jinjin Li, Jialin Li, Jiajia Ni, Caibo Zhang, Jianlei Jia, Guoying Wu, Hongzhao Sun, Shuzhen Wang. Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut MicrobiotaFrontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.752512
104
Youzhao Jiang, Liu Chen, Hui Wang, Bao Narisi, Bing Chen. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stressJournal of Ethnopharmacology 2015; 176: 499 doi: 10.1016/j.jep.2015.11.019
105
Milton Packer. Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver DiseaseThe American Journal of Medicine 2020; 133(2): 170 doi: 10.1016/j.amjmed.2019.09.002
106
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 755 doi: 10.1007/978-94-007-7675-3_37
107
Shankun Zhao, Yaoyao Wang, Weizhou Wu, Suqing Yang, Lili Feng, Fangfang Tao, Weiwei Ge, Maolei Shen, Weifang Xu. Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistanceAndrologia 2021; 53(6) doi: 10.1111/and.14060
108
Magdalena Świderska, Mateusz Maciejczyk, Anna Zalewska, Joanna Pogorzelska, Robert Flisiak, Adrian Chabowski. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patientsFree Radical Research 2019; 53(8): 841 doi: 10.1080/10715762.2019.1635691
109
S. A. Pavlovskyi. EVALUATION OF CONTENT OF CITOKINS IN PATIENTS� BLOOD WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2 UNDER THE INFLUENCE OF COMBINED SUCTIONAL THERAPYBulletin of Problems Biology and Medicine 2018; (144): 170 doi: 10.29254/2077-4214-2018-1-2-143-170-175
110
Yilizere Aibaidula, Mutalifu Aimaiti, Huiwen Tan, Bingting Chen, Jian Yang, Xiaoli Ma. Lactucin & Lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolismJournal of Pharmacological Sciences 2022; 150(2): 110 doi: 10.1016/j.jphs.2022.07.007
111
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese ChildrenCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3870454
112
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
113
Song Wang, Jian Wang, Yajing Liu, Hui Li, Qiao Wang, Zhiwei Huang, Wenbin Liu, Ping Shi. Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in MiceBiological Trace Element Research 2019; 187(1): 192 doi: 10.1007/s12011-018-1368-0
114
A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imagingBritish Journal of Biomedical Science 2019; 76(2): 70 doi: 10.1080/09674845.2019.1571555
115
Mooli Raja Gopal Reddy, Malleswarapu Mahesh, Munikumar Manne, Uday Kumar Putcha, Shanmugam M. Jeyakumar. Vitamin A and its metabolic pathway play a determinant role in high‐fructose‐induced triglyceride accumulation of the visceral adipose depot of male Wistar ratsCell Biochemistry and Function 2019; 37(8): 578 doi: 10.1002/cbf.3434
116
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individualsJournal of Gastroenterology and Hepatology 2021; 36(6): 1497 doi: 10.1111/jgh.15353
117
Emma Rose McGlone, Ahmed R. Ahmed. Global Bariatric Surgery2018; : 403 doi: 10.1007/978-3-319-93545-4_36
118
Hui Li, Mark J. Canet, John D. Clarke, Dean Billheimer, Stavra A. Xanthakos, Joel E. Lavine, Robert P. Erickson, Nathan J. Cherrington. Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic SteatohepatitisDrug Metabolism and Disposition 2017; 45(12): 1317 doi: 10.1124/dmd.117.077644
119
George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou, George K. Koukoulis. NAFLD and autoimmune hepatitis: Do not judge a book by its coverEuropean Journal of Internal Medicine 2020; 75: 1 doi: 10.1016/j.ejim.2020.02.001
120
Sumit Kar, Sabina Paglialunga, Sharon H. Jaycox, Rafiqul Islam, Angelo H. Paredes, Rohit Kohli. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosisPLOS ONE 2019; 14(7): e0217263 doi: 10.1371/journal.pone.0217263
121
Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4): 517 doi: 10.1111/ddg.14425
122
Susana Castro-Sánchez, Esteban Pérez-Giraldo, Juan Carlos Restrepo-Gutiérrez, Carlos E. Builes-Montaño. Enfermedad hepática grasa no alcohólica en personas no obesas: revisión narrativa de la literaturaHepatología 2021; : 223 doi: 10.52784/27112330.129
123
Narges Damavandi, Sirous Zeinali. Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver diseaseMolecular Biology Reports 2021; 48(2): 1225 doi: 10.1007/s11033-021-06142-1
124
Nadia Panera, Claudia Della Corte, Annalisa Crudele, Laura Stronati, Valerio Nobili, Anna Alisi. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokinesExpert Review of Gastroenterology & Hepatology 2016; 10(3): 393 doi: 10.1586/17474124.2016.1110485
125
Sifan Chen, Zhongliang Zhao, Liangru Ke, Zilun Li, Wenxue Li, Zili Zhang, Ying Zhou, Xiang Feng, Wei Zhu. Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1The Journal of Nutritional Biochemistry 2018; 55: 209 doi: 10.1016/j.jnutbio.2018.02.007
126
Marko Duvnjak, Sanja Stojsavljević, Lucija Virović Jukić, Lea Smirčić Duvnjak. Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLDJournal of Clinical and Translational Hepatology 2019; 7(2): 97 doi: 10.14218/JCTH.2019.00022
127
Simona Cernea, Andrada Larisa Roiban, Emőke Both, Adina Huţanu. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetesDiabetes/Metabolism Research and Reviews 2018; 34(8) doi: 10.1002/dmrr.3050
128
Claudia Calder�n‑Torres, Lirio Sarabia‑Curz, Yadira Ledesma‑Soto, Miguel Murgu�a‑Romero, Luis Terrazas‑Vald�s. Denitrase activity of Debaryomyces�hansenii reduces the oxidized compound 3‑nitrotyrosine in mice liver with colitisExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7395
129
Qiwen Pang, Zhen Sun, Chen Shao, Honghua Cai, Zhengyang Bao, Lin Wang, Lihua Li, Lele Jing, Lili Zhang, Zhongqun Wang. CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty LiverFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.583943
130
Rohith N. Thota, Jessica J. A. Ferguson, Kylie A. Abbott, Cintia B. Dias, Manohar L. Garg. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effectsvs. clinical outcomesFood & Function 2018; 9(7): 3576 doi: 10.1039/C8FO00348C
131
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbiditiesTerapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
132
Doaa El Amrousy, Dalia El-Afify. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver diseaseCytokine 2020; 135: 155215 doi: 10.1016/j.cyto.2020.155215
133
Stavroula Kanoni, Satish Kumar, Charalampia Amerikanou, Mary Jo Kurth, Maria G. Stathopoulou, Stephane Bourgeois, Christine Masson, Aimo Kannt, Lucia Cesarini, Maria-Spyridoula Kontoe, Maja Milanović, Francisco J. Roig, Mirjana Beribaka, Jonica Campolo, Nuria Jiménez-Hernández, Nataša Milošević, Carlos Llorens, Ilias Smyrnioudis, M. Pilar Francino, Nataša Milić, Andriana C. Kaliora, Maria Giovanna Trivella, Mark W. Ruddock, Milica Medić-Stojanoska, Amalia Gastaldelli, John Lamont, Panos Deloukas, George V. Dedoussis, Sophie Visvikis-Siest. Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLDFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.683028
134
Hong Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao, Li-Na Xu, Lian-Hong Yin, Yan Qi, Jin-Yong Peng. Herbal medicines and nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(30): 6890-6905 doi: 10.3748/wjg.v22.i30.6890
135
Jiawei Huang, Rumeng Jiang, Yonghong Wang. Effects of the probioticBacillus coagulansBC69 on the metabolic and histological alterations induced by a high-sugar and high-fat diet in C57BL/6J miceFood & Function 2023; 14(14): 6596 doi: 10.1039/D3FO01104F
136
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3Life Sciences 2021; 270: 119071 doi: 10.1016/j.lfs.2021.119071
137
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
138
Madeleine Themanns, Kristina M. Mueller, Sonja M. Kessler, Nicole Golob-Schwarzl, Thomas Mohr, Doris Kaltenecker, Jerome Bourgeais, Jamile Paier-Pourani, Katrin Friedbichler, Doris Schneller, Michaela Schlederer, Eva Zebedin-Brandl, Luigi M. Terracciano, Xiaonan Han, Lukas Kenner, Kay-Uwe Wagner, Wolfgang Mikulits, Andrey V. Kozlov, Markus H. Heim, Fabrice Gouilleux, Johannes Haybaeck, Richard Moriggl. Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in MiceScientific Reports 2016; 6(1) doi: 10.1038/srep34719
139
Jennifer C Price, Ruibin Wang, Eric C Seaberg, Matthew J Budoff, Lawrence A Kingsley, Frank J Palella , Mallory D Witt, Wendy S Post, Chloe L Thio. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus SerostatusOpen Forum Infectious Diseases 2017; 4(3) doi: 10.1093/ofid/ofx153
140
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver DiseaseLivers 2023; 3(4): 687 doi: 10.3390/livers3040045
141
Frédéric Hérault, Magalie Houée-Bigot, Elisabeth Baéza, Olivier Bouchez, Diane Esquerré, Christophe Klopp, Christian Diot. RNA-seq analysis of hepatic gene expression of common Pekin, Muscovy, mule and hinny ducks fed ad libitum or overfedBMC Genomics 2019; 20(1) doi: 10.1186/s12864-018-5415-1
142
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention StudyJournal of Medicinal Food 2019; 22(7): 729 doi: 10.1089/jmf.2018.0020
143
Gökay Taylan, Mustafa Ebik, Serdar Solak, Çağlar Kaya, Kenan Yalta. Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver diseaseRevista da Associação Médica Brasileira 2022; 68(10): 1428 doi: 10.1590/1806-9282.20220514
144
Bin Liu, Liping Xiang, Jing Ji, Wei Liu, Ying Chen, Mingfeng Xia, Yuejun Liu, Wenyue Liu, Peiwu Zhu, Yi Jin, Yu Han, Jieli Lu, Xiaoying Li, Minghua Zheng, Yan Lu. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2Journal of Clinical Investigation 2021; 131(20) doi: 10.1172/JCI144801
145
Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Słabczyńska, Martyna Kandefer-Szerszeń, Patricia Aspichueta. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha KetoglutaratePLOS ONE 2015; 10(12): e0143851 doi: 10.1371/journal.pone.0143851
146
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort studyIntestinal Research 2024;  doi: 10.5217/ir.2023.00078
147
Keke Lu, Jing Wang, Yueyuan Yu, Yikuan Wu, Zhao He. Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in miceFood Science & Nutrition 2020; 8(6): 2588 doi: 10.1002/fsn3.1445
148
Emily J. Onufer, Yong-Hyun Han, Cathleen Courtney, Allie Steinberger, Maria Tecos, Stephanie Sutton, Anne Sescleifer, Jocelyn Ou, Rafael Sanguinetti Czepielewski, Gwendalyn J. Randolph, Brad W. Warner. Liver injury after small bowel resection is prevented in obesity-resistant 129S1/SvImJ miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(5): G907 doi: 10.1152/ajpgi.00284.2020
149
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive reviewWorld Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
150
Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathwayInternational Immunopharmacology 2016; 38: 377 doi: 10.1016/j.intimp.2016.06.023
151
Cara Mack, Shikha S. Sundaram. Pediatric Gastrointestinal and Liver Disease2021; : 804 doi: 10.1016/B978-0-323-67293-1.00073-6
152
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?‎World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108
153
Helena A.P. Batatinha, Edson A. Lima, Alexandre A.S. Teixeira, Camila O. Souza, Luana A. Biondo, Loreana S. Silveira, Fabio S. Lira, José C. Rosa Neto. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR‐α Knockout MiceJournal of Cellular Physiology 2017; 232(5): 1008 doi: 10.1002/jcp.25440
154
Natalia Muñoz-Durango, Marco Arrese, Alejandra Hernández, Evelyn Jara, Alexis M. Kalergis, Daniel Cabrera. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse ModelFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.563434
155
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeuticsProstaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
156
Mei-Jou Chen, Hong-Nerng Ho. Hepatic manifestations of women with polycystic ovary syndromeBest Practice & Research Clinical Obstetrics & Gynaecology 2016; 37: 119 doi: 10.1016/j.bpobgyn.2016.03.003
157
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi H. Vasilev, Georgi V. Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, Latchezar Tomov, Antoaneta Mihova, Tsvetelina Velikova. Microbiome and Genetic Factors in the Pathogenesis of Liver DiseasesGastroenterology Insights 2023; 14(4): 575 doi: 10.3390/gastroent14040041
158
Shuangpeng Cai, Xiaoyu Cheng, Xueyin Pan, Jun Li. Emerging role of exosomes in liver physiology and pathologyHepatology Research 2017; 47(2): 194 doi: 10.1111/hepr.12794
159
Yaping Wang, Xiaobo Li, Shunlin Ren. Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical UsageMetabolites 2020; 11(1): 9 doi: 10.3390/metabo11010009
160
Jae B. Park, Renee Peters, Quynhchi Pham, Thomas T. Y. Wang. Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like CellsBiomedicines 2020; 8(6): 138 doi: 10.3390/biomedicines8060138
161
Ana Ninić, Marija Zdravković, Vojislav Radosavljević, Vera Gardijan, Lidija Memon, Jelena Vekić, Vesna Spasojević-Kalimanovska. Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apneaArhiv za farmaciju 2020; 70(6): 319 doi: 10.5937/arhfarm70-27586
162
K.K. Gao, F.-H. Li, Y.-M. Su, J. Wang, X.-M. Yu, L. Ruan, Y.-Z. Zhang. Impact of exercise intervention-based remote monitoring for patients with different grades of non-alcoholic fatty liver disease severityScience & Sports 2024; 39(1): 62 doi: 10.1016/j.scispo.2022.10.007
163
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver DiseaseRussian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
164
T.S. Sall, E.S. Shcherbakova, S.I. Sitkin, T.Ya. Vakhitov, I.G. Bakulin, E.V. Demyanova. Molecular mechanisms of non-alcoholic fatty liver disease developmentProfilakticheskaya meditsina 2021; 24(4): 120 doi: 10.17116/profmed202124041120
165
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related CancersInternational Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
166
J. E. Nelson, P. Handa, B. Aouizerat, L. Wilson, L. A. Vemulakonda, M. M. Yeh, K. V. Kowdley. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphismsAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1253 doi: 10.1111/apt.13824
167
Rocío Aller, Beatriz Burgueño Gomez, Rebeca Sigüenza, Conrado Fernández-Rodríguez, Natalia Fernández, Beatriz Antolín, Miguel Dur�, María Pina, Sara Lorenzo, Concepción García, Daniel de Luis Román. Comparative study of overweight and obese patients with nonalcoholic fatty liver diseaseRevista Española de Enfermedades Digestivas 2019;  doi: 10.17235/reed.2019.5926/2018
168
Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and BiomarkersMetabolites 2022; 12(11): 1073 doi: 10.3390/metabo12111073
169
Jie Wei, Yong-Zhan Zhen, Ju Cui, Fa-Lin He, Tao Shen, Gang Hu, Xiao-Hong Ren, Ya-Jun Lin. Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver diseaseArchives of Pharmacal Research 2016; 39(7): 960 doi: 10.1007/s12272-016-0770-4
170
Xin Hou, Shi Yin, Ruixue Ren, Siqi Liu, Liang Yong, Yuxiao Liu, Yu Li, Ming‐Hua Zheng, George Kunos, Bin Gao, Hua Wang. Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated FibrosisHepatology 2021; 74(1): 116 doi: 10.1002/hep.31658
171
Jennifer C Price, Yifei Ma, Mark H Kuniholm, Adaora A Adimora, Margaret Fischl, Audrey L French, Elizabeth T Golub, Deborah Konkle-Parker, Howard Minkoff, Ighovwerha Ofotokun, Michael Plankey, Anjali Sharma, Phyllis C Tien. Human Immunodeficiency Virus Is Associated With Elevated FibroScan–Aspartate Aminotransferase (FAST) ScoreClinical Infectious Diseases 2022; 75(12): 2119 doi: 10.1093/cid/ciac337
172
Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis. Adipokines in Liver CirrhosisInternational Journal of Molecular Sciences 2017; 18(7): 1392 doi: 10.3390/ijms18071392
173
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney diseaseObesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
174
Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos, Nelson Guardiola Meinhardt. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery PatientsObesity Surgery 2017; 27(8): 2151 doi: 10.1007/s11695-017-2627-4
175
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive reviewPhytochemistry Reviews 2023;  doi: 10.1007/s11101-023-09912-w
176
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signalingBiomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
177
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, Joo-Hyung Cho, Jinhua Cheng, Joo-Won Suh. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut MicrobiotaInternational Journal of Molecular Sciences 2022; 23(21): 13436 doi: 10.3390/ijms232113436
178
Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro studyCancer Biomarkers 2017; 20(4): 411 doi: 10.3233/CBM-170157
179
Malleswarapu Mahesh, Munugala Bharathi, Mooli Raja Gopal Reddy, Pranati Pappu, Uday Kumar Putcha, Ayyalasomayajula Vajreswari, Shanmugam M Jeyakumar. Carrot juice ingestion attenuates high fructose‐induced circulatory pro‐inflammatory mediators in weanling Wistar ratsJournal of the Science of Food and Agriculture 2017; 97(5): 1582 doi: 10.1002/jsfa.7906
180
Gopanandan Parthasarathy, Xavier Revelo, Harmeet Malhi. Pathogenesis of Nonalcoholic Steatohepatitis: An OverviewHepatology Communications 2020; 4(4): 478 doi: 10.1002/hep4.1479
181
Jaqueline Pereira Lana, Laís Bhering Martins, Marina Chaves de Oliveira, Zélia Menezes-Garcia, Letícia Tamie Pavia Yamada, Leda Quercia Vieira, Mauro Martins Teixeira, Adaliene Versiani Matos Ferreira. TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditionsApplied Physiology, Nutrition, and Metabolism 2016; 41(12): 1295 doi: 10.1139/apnm-2016-0265
182
Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomenaLiver Research 2022; 6(2): 72 doi: 10.1016/j.livres.2022.05.002
183
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_37-1
184
Li Xue, Xiaolan Lu, Juntao He, Ting Zhang, Xiaokang Wu, Yanping Zhang, Ningning Wang, Zhe An, Jiru Xu, Yan Geng. Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat modelPathology - Research and Practice 2018; 214(11): 1778 doi: 10.1016/j.prp.2018.08.016
185
Vera Lede, Andrej Meusel, Antje Garten, Yulia Popkova, Melanie Penke, Christin Franke, Albert Ricken, Angela Schulz, Wieland Kiess, Daniel Huster, Torsten Schöneberg, Jürgen Schiller, Yanqiao Zhang. Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptorPLOS ONE 2017; 12(2): e0172000 doi: 10.1371/journal.pone.0172000
186
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis BreakdownFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
187
Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and CancerRecent Results in Cancer Research 2016; 208: 177 doi: 10.1007/978-3-319-42542-9_10
188
Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot studyPLOS ONE 2021; 16(11): e0260313 doi: 10.1371/journal.pone.0260313
189
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7653689
190
Xu Zhang, Xuetao Ji, Qian Wang, John Zhong Li. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)Protein & Cell 2018; 9(2): 164 doi: 10.1007/s13238-017-0436-0
191
Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra. Pathophysiological mechanisms underlying MAFLDDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(6): 1875 doi: 10.1016/j.dsx.2020.09.026
192
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70721
193
Veeravich Jaruvongvanich, Anawin Sanguankeo, Tanawan Riangwiwat, Sikarin Upala. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisAnnals of Hepatology 2017; 16(3): 382 doi: 10.5604/01.3001.0009.8593
194
Dongxu Wang, Qiang Gao, Taotao Wang, Zhipeng Kan, Xin Li, Lizhen Hu, Chuan-yi Peng, Frank Qian, Yijun Wang, Daniel Granato. Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activationFood Research International 2020; 127: 108628 doi: 10.1016/j.foodres.2019.108628
195
Kui Peng, Lin Lin, Zhengyi Wang, Lin Ding, Ya Huang, Po Wang, Yu Xu, Jieli Lu, Min Xu, Yufang Bi, Weiqing Wang, Yuhong Chen, Guang Ning. Short sleep duration and longer daytime napping are associated with non‐alcoholic fatty liver disease in Chinese adultsJournal of Diabetes 2017; 9(9): 827 doi: 10.1111/1753-0407.12489
196
Paloma Gallego, Amparo Luque-Sierra, Gonzalo Falcon, Pilar Carbonero, Lourdes Grande, Juan D. Bautista, Franz Martín, José A. Del Campo. White Button Mushroom Extracts Modulate Hepatic Fibrosis Progression, Inflammation, and Oxidative Stress In Vitro and in LDLR-/- MiceFoods 2021; 10(8): 1788 doi: 10.3390/foods10081788
197
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering stormAIDS 2019; 33(7): 1105 doi: 10.1097/QAD.0000000000002161
198
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanismsProceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
199
Maria Jimenez Ramos, Lucia Bandiera, Filippo Menolascina, Jonathan Andrew Fallowfield. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applicationsiScience 2022; 25(1): 103549 doi: 10.1016/j.isci.2021.103549
200
Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Anna Kasprzyk-Pawelec, Shreyas Gadre, Erika Parasido, Olga Catalina-Rodriguez, Patricia Foley, Giuseppe Giaccone, Amrita Cheema, Bhaskar Kallakury, Chris Albanese, Chunling Yi, Maria Laura Avantaggiati. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASHCell Death & Differentiation 2020; 27(7): 2143 doi: 10.1038/s41418-020-0491-6
201
Ekrem Aksu, Abdullah Sokmen, Murat Ispiroglu, Kadir Gisi, Enes Celik, Ahmet Cagri Aykan. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver diseaseKardiologiia 2021; 61(5): 51 doi: 10.18087/cardio.2021.5.n1416
202
AhmedM M. Mahmouda, NohaA.-R A. El-Hagag, HusseinI El-Bitar, Abdel-HalimM Afifi. Potential protective effect of curcumin in high-fat diet-induced nonalcoholic fatty liver disease in ratsJournal of Current Medical Research and Practice 2021; 6(1): 92 doi: 10.4103/JCMRP.JCMRP_37_20
203
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver DiseaseAngiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
204
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver diseasePLOS ONE 2020; 15(2): e0219412 doi: 10.1371/journal.pone.0219412
205
Mohamed M.A. Hussein, Hussein I. El-Belbasi, Mohamed A. Morsy, Islam M. Saadeldin, Ghedeir M. Alshammari. The synergistic effect of fenretinide and metformin to achieve a decrease in insulin resistance and inflammatory mediators: an in vivo studyAll Life 2020; 13(1): 108 doi: 10.1080/26895293.2020.1732483
206
Nadia Panera, Barbara Barbaro, Claudia Della Corte, Antonella Mosca, Valerio Nobili, Anna Alisi. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver diseaseNutrition Research 2018; 58: 1 doi: 10.1016/j.nutres.2018.05.002
207
M Pallavi, MM Suchitra, P.V.L.N Srinivasa Rao. Role of adipokines in the pathogenesis of nonalcoholic fatty liver diseaseJournal of Clinical and Scientific Research 2015; 4(1): 31 doi: 10.15380/2277-5706.JCSR.14.072
208
Peter Müller, Marie Messmer, Monika Bayer, Josef M. Pfeilschifter, Edith Hintermann, Urs Christen. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse modelJournal of Autoimmunity 2016; 69: 51 doi: 10.1016/j.jaut.2016.02.007
209
Min-Gyung Kang, Hee Jae Lee, Jae-Young Cho, Kanghwa Kim, Soo Jin Yang, Doman Kim. Anti-inflammatory effects of sucrose-derived oligosaccharides produced by a constitutive mutant L. mesenteroides B-512FMCM dextransucrase in high fat diet-fed miceBiochemical and Biophysical Research Communications 2016; 477(3): 350 doi: 10.1016/j.bbrc.2016.06.102
210
Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trialFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
211
Chen Shen, Jin Hong Chen, Ha Ram Oh, Ji Hyun Park. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36FEBS Letters 2021; 595(19): 2493 doi: 10.1002/1873-3468.14193
212
F. Hérault, C. Duby, E. Baéza, C. Diot. Adipogenic genes expression in relation to hepatic steatosis in the liver of two duck speciesAnimal 2018; 12(12): 2571 doi: 10.1017/S1751731118000897
213
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
214
Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky. Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver diseaseClinical and Molecular Hepatology 2020; 26(2): 216 doi: 10.3350/cmh.2019.0074
215
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver DiseaseAdvances in Nutrition 2021; 12(2): 413 doi: 10.1093/advances/nmaa106
216
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging TherapiesLivers 2023; 3(4): 637 doi: 10.3390/livers3040042
217
Ana Elenka Ortíz-Reyes, C. Marissa Calderón-Torres. INCREMENTO DE LA EXPRESIÓN DE TLR4 Y EFECTO ANTIOXIDANTE DEL ÁCIDO ACETILSALICÍLICO EN CONEJOS CON DIETA ALTA EN GRASASRESPYN Revista Salud Pública y Nutrición 2017; 16(2): 1 doi: 10.29105/respyn16.2-1
218
Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Nicht‐alkoholische Fettlebererkrankung und Psoriasis – besteht ein gemeinsames proinflammatorisches Netzwerk?JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4): 517 doi: 10.1111/ddg.14425_g
219
Xingcen Chen, Ruyi Peng, Dongzi Peng, Jia Xiao, Deliang Liu, Rong Li. An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? why is this subject of interest?Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1282956
220
Pavel Kraml. Lipid-lowering therapy in selected specific groups of patientsMedicína pro praxi 2020; 17(3): 151 doi: 10.36290/med.2020.029
221
Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathwaysJournal of Pharmacy and Pharmacology 2023; 75(7): 985 doi: 10.1093/jpp/rgad044
222
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advancesThe Journal of Pathology 2017; 241(1): 36 doi: 10.1002/path.4829
223
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic reviewInternational Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
224
Patrícia de Castro-de-Paiva, Thatiany de Souza Marinho, Carlos Alberto Mandarim-de-Lacerda, Marcia Barbosa Aguila. Intermittent fasting, high-intensity interval training, or a combination of both have beneficial effects in obese mice with nonalcoholic fatty liver diseaseThe Journal of Nutritional Biochemistry 2022; 104: 108997 doi: 10.1016/j.jnutbio.2022.108997
225
Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und NierenkrankheitenDie Nephrologie 2022; 17(5): 291 doi: 10.1007/s11560-022-00595-6
226
J.E. Davis, J. Cain, C. Small, D.B. Hales. Therapeutic effect of flax-based diets on fatty liver in aged laying hensPoultry Science 2016; 95(11): 2624 doi: 10.3382/ps/pew160
227
Bai Ruiyang, Adriana Panayi, Wu Ruifang, Zhang Peng, Fu Siqi. Adiponectin in psoriasis and its comorbidities: a reviewLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01510-z
228
Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant featuresPathology International 2018; 68(1): 12 doi: 10.1111/pin.12612
229
Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini. Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic reviewFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1037696